Ebola Has Passed 1,000 Cases. This Outbreak Is Different From Any Before

More than 1,000 cases of Ebola have been confirmed in the DRC in 2026. A comparison of three major outbreaks shows how unusual this trajectory is — and what the absence of a vaccine means for the response.

How The OMB Rule Could Hurt You And Your Town

The OMB proposal threatens scientific research and ALL federal funding for states, cities, and nonprofits. It politicizes ALL funding. Call your reps and write an objection.

Demand For Healthy Homes Drives Products And Builders Together

Healthy homes are in high demand and buyers are willing to pay for the features that will mean more comfort and longer, healthy lives.

These 29-Year-Olds’ AI Chatbot For Scheduling Doctor Visits Is Now Worth $1.2 Billion

Scheduling doctor appointments is its own form of hell for both physicians and patients. Assort Health’s AI fix helped it raise its third venture round in 14 months.

The Rising Threat Of Tick-Borne Diseases In America—Here’s What To Know

A public health expert explains why tick-borne diseases are on the rise, what they are, and how to keep yourself and loved ones protected.

At 250, America Must Make Good On Its Promise Of Opportunity

America’s future depends on expanding opportunity while preserving merit and competition. Creating opportunity is critical to improving our strength and competitiveness.

What To Know About Tests That Promise To Reveal Your Biological Age

The concept of biological age, distinct from chronological age, is gaining public traction, though often misinterpreted. “Aging clocks” are real, but beware of hype.

Home Medical Kits And Antibiotic Resistance: A Preventable Collision

Companies are aggressively marketing home medical kits containing prescription antibiotics and other drugs for self-treatment, bypassing traditional medical evaluation.

This Startup Says It Saves Medicare More Than $2 Million A Week

Cadence reached a $1.2 billion valuation by using AI to track seniors’ chronic health conditions and improve their care.

A New Way To Hit Pancreatic Cancer’s Hardest Target

A first-in-class nanoparticle injection sneaks antibodies into pancreatic cancer cells to clear mutant KRAS, shrinking tumors in mice while sparing healthy tissue.